Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion type Assertion NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_head.
- NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_provenance.
- NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion evidence source_evidence_literature NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_provenance.
- NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion SIO_000772 24448243 NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_provenance.
- NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion wasDerivedFrom befree-20150227 NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_provenance.
- NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion wasGeneratedBy ECO_0000203 NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_provenance.